Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - suspension - 10mcg - hepatitis b surface antigen (recombinant) 10mcg - vaccines

Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - suspension - 40mcg - hepatitis b surface antigen (recombinant) 40mcg - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - octocog alfa; recombinant coagulation factor viii -

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - antihemophilic factor, human recombinant (unii: p89dr4ny54) (antihemophilic factor, human recombinant - unii:p89dr4ny54) - the use of recombinate [antihemophilic factor (recombinant)] is indicated in hemophilia a (classical hemophilia) for the prevention and control of hemorrhagic episodes.2 recombinate is also indicated in the perioperative management of patients with hemophilia a (classical hemophilia). recombinate can be of therapeutic value in patients with acquired factor viii inhibitors not exceeding 10 bethesda units per ml.3   in clinical studies with recombinate, patients with inhibitors who were entered into the previously treated patient trial and those previously untreated children who have developed inhibitor activity on study, showed clinical hemostatic response when the titer of inhibitor was less than 10 bethesda units per ml. however, in such uses, the dosage of recombinate should be controlled by frequent laboratory determinations of circulating factor viii levels as well as the clinical status of the patient. recombinate is not indicated in von willebrand’s disease. recombinate is contraindicated in patients w

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - recombinant omega interferon of feline origin - unknown - recombinant omega interferon of feline origin vaccine active 0.0 - active constituent

Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - solution - 10mcg - hepatitis b surface antigen (recombinant) 10mcg - vaccines

Canada - English - Health Canada

merck canada inc - hepatitis b surface antigen (recombinant) - solution - 40mcg - hepatitis b surface antigen (recombinant) 40mcg - vaccines

Canada - English - Health Canada

baxter healthcare corporation - antihemophilic factor (recombinant) - powder for solution - 250unit - antihemophilic factor (recombinant) 250unit - hemostatics

Canada - English - Health Canada

baxter healthcare corporation - antihemophilic factor (recombinant) - powder for solution - 1000unit - antihemophilic factor (recombinant) 1000unit - hemostatics

Canada - English - Health Canada

baxter healthcare corporation - antihemophilic factor (recombinant) - powder for solution - 500unit - antihemophilic factor (recombinant) 500unit - hemostatics